WO2017164659A3 - Procédé d'étude de la capacité d'une substance naturelle à renforcer l'immunocompétence et procédé de fourniture d'un régime personnalisé l'utilisant - Google Patents

Procédé d'étude de la capacité d'une substance naturelle à renforcer l'immunocompétence et procédé de fourniture d'un régime personnalisé l'utilisant Download PDF

Info

Publication number
WO2017164659A3
WO2017164659A3 PCT/KR2017/003107 KR2017003107W WO2017164659A3 WO 2017164659 A3 WO2017164659 A3 WO 2017164659A3 KR 2017003107 W KR2017003107 W KR 2017003107W WO 2017164659 A3 WO2017164659 A3 WO 2017164659A3
Authority
WO
WIPO (PCT)
Prior art keywords
individual subjects
natural material
immunocompetence
examining
providing customized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2017/003107
Other languages
English (en)
Korean (ko)
Other versions
WO2017164659A2 (fr
Inventor
백강민
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ontle Union
Original Assignee
Ontle Union
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ontle Union filed Critical Ontle Union
Publication of WO2017164659A2 publication Critical patent/WO2017164659A2/fr
Publication of WO2017164659A3 publication Critical patent/WO2017164659A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6866—Interferon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La présente invention concerne un procédé d'étude de l'immunocompétence de divers sujets, dans lequel des échantillons de sang prélevés chez divers sujets sont additionnés de cellules antigéniques et analysés pour déterminer le nombre de cellules antigéniques détruites et les taux de cytokines, dont ceux d'IFN-γ. La présente invention concerne un procédé d'étude de la mesure dans laquelle une substance naturelle renforce l'immunocompétence de divers sujets, les échantillons de sang prélevés chez les divers sujets étant additionnés de cellules antigéniques et de ladite substance naturelle et analysés pour déterminer le nombre de cellules antigéniques détruites et le taux de cytokines, dont celui d'IFN-γ. La présente invention concerne un procédé visant à fournir des régimes personnalisés pour renforcer l'immunocompétence de divers sujets, comprenant la détermination et la sélection de substances naturelles à des fins d'immunopotentialisation des divers sujets.
PCT/KR2017/003107 2016-03-23 2017-03-23 Procédé d'étude de la capacité d'une substance naturelle à renforcer l'immunocompétence et procédé de fourniture d'un régime personnalisé l'utilisant Ceased WO2017164659A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020160034495A KR20170110297A (ko) 2016-03-23 2016-03-23 천연물 소재의 면역증강 검사법 및 상기 검사법을 활용한 맞춤형 식단 제공방법
KR10-2016-0034495 2016-03-23

Publications (2)

Publication Number Publication Date
WO2017164659A2 WO2017164659A2 (fr) 2017-09-28
WO2017164659A3 true WO2017164659A3 (fr) 2018-09-07

Family

ID=59900515

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2017/003107 Ceased WO2017164659A2 (fr) 2016-03-23 2017-03-23 Procédé d'étude de la capacité d'une substance naturelle à renforcer l'immunocompétence et procédé de fourniture d'un régime personnalisé l'utilisant

Country Status (2)

Country Link
KR (1) KR20170110297A (fr)
WO (1) WO2017164659A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101981146B1 (ko) * 2018-03-26 2019-05-22 충남대학교산학협력단 수지상 세포를 이용한 면역 소재의 면역증진 효과 평가방법 및 면역 소재 스크리닝 방법
KR101981147B1 (ko) * 2018-09-27 2019-05-22 충남대학교산학협력단 수지상세포를 이용한 면역 소재의 면역증진 효과 평가방법 및 면역 소재 스크리닝 방법
CA3237260A1 (fr) * 2021-11-03 2023-05-11 Samuel REICHBERG Test pour predire et evaluer des reponses immunitaires innees a des infections et procedes de traitement de celles-ci

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040047899A (ko) * 2002-10-08 2004-06-05 오리엔트 캔서 세라피 컴퍼니 리미티드 신규한 면역활성 측정방법
JP2006506609A (ja) * 2002-11-08 2006-02-23 セレスティス リミテッド 細胞性免疫応答を測定する診断アッセイ法
JP4359684B2 (ja) * 2003-09-17 2009-11-04 独立行政法人農業・食品産業技術総合研究機構 ヨーネ病の検査方法
KR20110010030A (ko) * 2009-07-23 2011-01-31 주식회사 해림후코이단 식품 선택을 위한 면역검사시스템

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040047899A (ko) * 2002-10-08 2004-06-05 오리엔트 캔서 세라피 컴퍼니 리미티드 신규한 면역활성 측정방법
JP2006506609A (ja) * 2002-11-08 2006-02-23 セレスティス リミテッド 細胞性免疫応答を測定する診断アッセイ法
JP4359684B2 (ja) * 2003-09-17 2009-11-04 独立行政法人農業・食品産業技術総合研究機構 ヨーネ病の検査方法
KR20110010030A (ko) * 2009-07-23 2011-01-31 주식회사 해림후코이단 식품 선택을 위한 면역검사시스템

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
YUMINAMOCHI: "Interleukin-12- and interferon-gamma-mediated natural killer cell activation by Agaricus blazei Murill", IMMUNOLOGY, vol. 121, 2007, pages 197 - 206, XP055538404 *

Also Published As

Publication number Publication date
KR20170110297A (ko) 2017-10-11
WO2017164659A2 (fr) 2017-09-28

Similar Documents

Publication Publication Date Title
WO2020123316A3 (fr) Procédés de détermination d'un emplacement d'un analyte biologique dans un échantillon biologique
SG11202109251QA (en) Multi-Channel Microfluidic Blood Coagulation Detection Chip Having Five-Layer Structure
WO2017040930A3 (fr) Biomarqueurs prédictifs du syndrome de libération de cytokines
BR112017025297A2 (pt) anticorpos anti-gitr para diagnóstico do câncer
AU2018261622A1 (en) Diagnostic advanced glycation end-product antibodies
EP4582812A3 (fr) Dosages pour détecter la présence ou la quantité d'un anticorps anti-médicament
MX2021006897A (es) Acidos nucleicos libres de celulas para el analisis del microbioma humano y componentes del mismo.
WO2015200893A3 (fr) Procédés d'analyse d'acides nucléiques provenant de cellules individuelles ou de populations de cellules
EP4609741A3 (fr) Elément de refroidissement d'aérosol et agencements à utiliser avec un appareil pour chauffer une matière fumable
EP4663746A3 (fr) Bactériothérapie de colite de clostridium difficile
PL413090A1 (pl) Startery, sposób mikrobiologicznej analizy materiału biologicznego, zastosowanie metody sekwencjonowania NGS w diagnostyce mikrobiologicznej i zestaw diagnostyczny
WO2015175301A8 (fr) Dispositif de diagnostic urinaire flexible et intégré
WO2017164659A3 (fr) Procédé d'étude de la capacité d'une substance naturelle à renforcer l'immunocompétence et procédé de fourniture d'un régime personnalisé l'utilisant
WO2015153948A3 (fr) Imagerie de microtentacule d'échantillons de tumeur d'un patient
AR106214A1 (es) Composiciones y métodos para la detección rápida de salmonella
HK1232238A1 (zh) 检测人类骨膜蛋白的新型测定
IT201700030715A1 (it) Procedimento per determinare la capacità antiossidante di un campione biologico e relativo kit.
WO2018026969A3 (fr) Anticorps contre la plazomicine et procédés d'utilisation
EP4006553A4 (fr) Composant de test d'antigène de groupe sanguin
EP3908827A4 (fr) Dispositif et procédés de séparation et d'analyse du sang
Erro et al. SPG31 presenting with orthostatic tremor
WO2016112261A3 (fr) Dosage pour détecter la dpp-4 humaine
MX2019005166A (es) Antigenos para detectar infeccion por toxoplasma mediante el monitoreo de la inmunidad celular.
EP3996500B8 (fr) Séparateur de nymphes et dispositif de sexage
WO2016168741A8 (fr) Détection de cytomégalovirus humain

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17770629

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 17770629

Country of ref document: EP

Kind code of ref document: A2